Finch Therapeutics Group, Inc.

The momentum for this stock is not very good. Finch Therapeutics Group, Inc. is not very popular among insiders. Tradey thinks it is not wise to invest in Finch Therapeutics Group, Inc..

News

FNCH Stock Earnings: Finch Therapeutics Gr Reported Results for Q1 2024

InvestorPlace InvestorPlace - Stock Market News, Stock Advice & Trading Tips\nFinch Therapeutics Gr just reported results for the first quarter of 2024.\nThe post FNCH Stock Earnings: Finch Therapeutics Gr Reported...\n more…

Finch Therapeutics Group, Inc. (NASDAQ:FNCH) Short Interest Update

Ticker Report Finch Therapeutics Group, Inc. (NASDAQ:FNCH - Get Free Report) was the target of a significant increase in short interest during the month of April. As of April 15th, there was short interest...\n more…

Finch Therapeutics Group (NASDAQ:FNCH) Trading Down 5.1%

Zolmax Finch Therapeutics Group, Inc. (NASDAQ:FNCH - Get Free Report) shares traded down 5.1% during trading on Friday . The company traded as low as $2.16 and last traded at $2.24. 29,863 shares were...\n more…

Finch Therapeutics Group (NASDAQ:FNCH) versus Jasper Therapeutics (NASDAQ:JSPR) Financial Survey

Zolmax Finch Therapeutics Group (NASDAQ:FNCH - Get Free Report) and Jasper Therapeutics (NASDAQ:JSPR - Get Free Report) are both small-cap medical companies, but which is the better business? We will...\n more…

12 titoli sanitari in movimento, after-market del 08/04/2024

Benzinga Titoli in rialzo Le azioni di Kineta (NASDAQ:KA) hanno guadagnato l'11,21% a 0,60 dollari durante la sessione after-market di lunedì. Le azioni di Finch Therapeutics Gr (NASDAQ:FNCH) sono salite dell'8,96% a 2,43\n more…

Finch Therapeutics Group (NASDAQ:FNCH) versus AIM ImmunoTech (NYSE:AIM) Head-To-Head Survey

Ticker Report AIM ImmunoTech (NYSE:AIM - Get Free Report) and Finch Therapeutics Group (NASDAQ:FNCH - Get Free Report) are both small-cap medical companies, but which is the superior stock? We will contrast the...\n more…